Task Forces
- Taskforce for Patient-centred Programmatic Management of Drug-resistant Tuberculosis (PMDT) - (closed)
- GDI Triage Task Force - (active)
- Taskforce on Advocacy for PMDT - (closed)
- DR-TB STAT - (active)
- TB, Human Rights and the Law Task Force - (active)
DR-TB STAT: Update on Programmatic Introduction of New TB Drugs
DR-TB STAT, an officially recognized task force of the Global Drug-Resistance Initiative (GDI) since July, 2015, continues to host monthly meetings to facilitate the introduction of bedaquiline and delamanid under program conditions. The group, which was formed in response to the "Call to Action" on new drug introduction, began meeting in May of 2015 and has reviewed the progress of new drug introduction in key countries, including South Africa, India, Indonesia, Georgia, the Philippines, Lesotho, Kenya, Swaziland, Peru and Vietnam. Multiple stakeholders have come together during the calls to help troubleshoot issues in new drug introduction.
DR-TB STAT Global Data March 2018
Global Update Maps are provided below:
